Is There A Survival Benefit For Patients Who Receive Post-Operative Adjuvant Chemotherapy Following Secondary Cytoreductive Surgery (Scrs) For Recurrent Epithelial Ovarian Cancer (Eoc)?
EUROPEAN JOURNAL OF CANCER（2015）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要